217 related articles for article (PubMed ID: 37531161)
41. New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.
Hao L; Li S; Hu X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12543-12560. PubMed ID: 37423958
[TBL] [Abstract][Full Text] [Related]
42. NR4a1/2 deletion promotes accumulation of TCF1
Srirat T; Hayakawa T; Mise-Omata S; Nakagawara K; Ando M; Shichino S; Ito M; Yoshimura A
Cell Rep; 2024 Mar; 43(3):113898. PubMed ID: 38451819
[TBL] [Abstract][Full Text] [Related]
43. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
Winkler F; Bengsch B
Front Immunol; 2019; 10():3039. PubMed ID: 32038613
[TBL] [Abstract][Full Text] [Related]
44. The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment.
Neupane P; Mimura K; Nakajima S; Okayama H; Ito M; Thar Min AK; Saito K; Onozawa H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Kono K
Anticancer Res; 2021 Oct; 41(10):4895-4905. PubMed ID: 34593437
[TBL] [Abstract][Full Text] [Related]
45. Hyperactivation and enhanced cytotoxicity of reduced CD8
Zhu T; Zhu L; Sheng C; Wu D; Gu Q; Jiang Z; Xu J; Fu G; Jiang Y
BMC Immunol; 2024 Feb; 25(1):15. PubMed ID: 38336646
[TBL] [Abstract][Full Text] [Related]
46. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Nagasaki J; Inozume T; Sax N; Ariyasu R; Ishikawa M; Yamashita K; Kawazu M; Ueno T; Irie T; Tanji E; Morinaga T; Honobe A; Ohnuma T; Yoshino M; Iwata T; Kawase K; Sasaki K; Hanazawa T; Kochin V; Kawamura T; Matsue H; Hino M; Mano H; Suzuki Y; Nishikawa H; Togashi Y
Cell Rep; 2022 Feb; 38(5):110331. PubMed ID: 35108529
[TBL] [Abstract][Full Text] [Related]
47. Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR; Hao Y; Ahsan A; Wu J; Qian Y; Zhong H; Loeb S; Makarov DV; Lepor H; Wysock J; Taneja SS; Huang WC; Becker DJ; Balar AV; Melamed J; Deng FM; Ren Q; Kufe D; Wong KK; Adeegbe DO; Deng J; Wise DR
Prostate; 2023 Jun; 83(9):840-849. PubMed ID: 36988342
[TBL] [Abstract][Full Text] [Related]
48. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer.
Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS
Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487
[TBL] [Abstract][Full Text] [Related]
49. Differential regulation of CD8
Li C; Lin YD; Wang WB; Xu M; Zhang N; Xiong N
Eur J Immunol; 2022 Sep; 52(9):1498-1509. PubMed ID: 35581932
[TBL] [Abstract][Full Text] [Related]
50. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
51. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Giordano M; Henin C; Maurizio J; Imbratta C; Bourdely P; Buferne M; Baitsch L; Vanhille L; Sieweke MH; Speiser DE; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
EMBO J; 2015 Aug; 34(15):2042-58. PubMed ID: 26139534
[TBL] [Abstract][Full Text] [Related]
52. Type 17 immunity promotes the exhaustion of CD8
Kim BS; Kuen DS; Koh CH; Kim HD; Chang SH; Kim S; Jeon YK; Park YJ; Choi G; Kim J; Kang KW; Kim HY; Kang SJ; Hwang S; Shin EC; Kang CY; Dong C; Chung Y
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083422
[TBL] [Abstract][Full Text] [Related]
53. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
54. Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment.
Yang M; Du W; Yi L; Wu S; He C; Zhai W; Yue C; Sun R; Menk AV; Delgoffe GM; Jiang J; Lu B
Oncoimmunology; 2020; 9(1):1708064. PubMed ID: 32076578
[TBL] [Abstract][Full Text] [Related]
55. CD38 marks the exhausted CD8
Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
[TBL] [Abstract][Full Text] [Related]
56. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
57. Stat5 opposes the transcription factor Tox and rewires exhausted CD8
Beltra JC; Abdel-Hakeem MS; Manne S; Zhang Z; Huang H; Kurachi M; Su L; Picton L; Ngiow SF; Muroyama Y; Casella V; Huang YJ; Giles JR; Mathew D; Belman J; Klapholz M; Decaluwe H; Huang AC; Berger SL; Garcia KC; Wherry EJ
Immunity; 2023 Dec; 56(12):2699-2718.e11. PubMed ID: 38091951
[TBL] [Abstract][Full Text] [Related]
58. Phenotype molding of T cells in colorectal cancer by single-cell analysis.
Di J; Liu M; Fan Y; Gao P; Wang Z; Jiang B; Su X
Int J Cancer; 2020 Apr; 146(8):2281-2295. PubMed ID: 31901134
[TBL] [Abstract][Full Text] [Related]
59. Immune phenotypic linkage between colorectal cancer and liver metastasis.
Liu Y; Zhang Q; Xing B; Luo N; Gao R; Yu K; Hu X; Bu Z; Peng J; Ren X; Zhang Z
Cancer Cell; 2022 Apr; 40(4):424-437.e5. PubMed ID: 35303421
[TBL] [Abstract][Full Text] [Related]
60. Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.
Guo L; Cao C; Goswami S; Huang X; Ma L; Guo Y; Yang B; Li T; Chi Y; Zhang X; Wu J
Clin Sci (Lond); 2020 Apr; 134(7):711-726. PubMed ID: 32202617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
